Herbas VPB

Print
EN | LT
LT - ORAL FORMULATION AND SUSPENSION OF AN ONCOLOGY DRUG
EN - ORAL FORMULATION AND SUSPENSION OF AN ONCOLOGY DRUG

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 9/10 (2006.01)
A61K 47/14 (2013.01)
A61K 47/14 (2017.01)
A61K 9/0095 (2013.01)
A61K 31/5377 (2006.01)
A61K 9/10 (2013.01)
A61P 35/00 (2006.01)
A61K 31/5377 (2013.01)
A61P 35/00 (2018.01)
European patent
(11) Number of the document 2958550
(13) Kind of document T
(96) European patent application number 14710642.1
Date of filing the European patent application 2014-02-21
(97) Date of publication of the European application 2015-12-30
(45) Date of publication and mention of the grant of the patent 2022-08-17
(46) Date of publication of the claims translation
PCT application
(86) Number PCT/IB2014/059161
Date 2014-02-21
PCT application publication
(87) Number WO 2014/128661
Date 2014-08-28
Priority applications
(30) Number Date Country code
201361768803 P 2013-02-25 US
Inventors
(72)
DECAUDIN, Céline , CH
ROGUE, Vincent , CH
Grantee
(73) Sun Pharmaceutical Industries Limited , SPARC, TANDALJA, Vadodara, Gujarat-390012, IN
Title
(54) ORAL FORMULATION AND SUSPENSION OF AN ONCOLOGY DRUG
  ORAL FORMULATION AND SUSPENSION OF AN ONCOLOGY DRUG